Thomas A. Munro

发表

Revised (β-phenyl) stereochemistry of ultrapotent μ opioid BU72

Thomas A. Munro, 2020, bioRxiv.

Selective κ Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters

Bryan L. Roth, Nicola A. Colabufo, F. Ivy Carroll, 2013, PloS one.

Salvinorin A and derivatives: Protection from metabolism does not prolong short-term, whole-brain residence

Jacob M. Hooker, David Alexoff, Cécile Béguin, 2009, Neuropharmacology.

Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial

B. Cohen, G. Galloway, M. Baggott, 2010, Psychopharmacology.

The BU72-μ opioid receptor crystal structure is a covalent adduct

Thomas A. Munro, 2020 .

Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity

B. Cohen, Wei Xu, L. Liu-Chen, 2013, Beilstein journal of organic chemistry.

Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A.

M. Rizzacasa, Thomas A. Munro, 2003, Journal of natural products.

Functional Selectivity of 6′-Guanidinonaltrindole (6′-GNTI) at κ-Opioid Receptors in Striatal Neurons*

L. Bohn, Lei Zhou, J. Streicher, 2013, The Journal of Biological Chemistry.

N -Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective (cid:1) -Opioid Receptor Agonist with Oral Efficacy □ S

B. Cohen, B. Roth, W. Carlezon, 2007 .

8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor

Katharine K. Duncan, B. Cohen, Wei Xu, 2007, Beilstein journal of organic chemistry.

Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum.

R. Robins-Browne, M. Rizzacasa, Thomas A. Munro, 2003, Journal of natural products.

The chemistry of Salvia divinorum

Thomas A. Munro, 2006 .

Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.

Bryan L Roth, B. Roth, M. Rizzacasa, 2005, Journal of medicinal chemistry.

Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity

B. Cohen, W. Carlezon, F. Carroll, 2012, BMC pharmacology.

N-Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective κ-Opioid Receptor Agonist with Oral Efficacy

B. Cohen, B. Roth, Wei Xu, 2008, Journal of Pharmacology and Experimental Therapeutics.

N-methylacetamide analogue of salvinorin A: a highly potent and selective kappa opioid receptor agonist with oral efficacy

B. Cohen, B. Roth, W. Carlezon, 2007 .

Sci-Hub provides access to nearly all scholarly literature

Casey S Greene, Stephen Reid McLaughlin, Daniel S. Himmelstein, 2018, eLife.

Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial

B. Cohen, G. Galloway, M. Baggott, 2010, Psychopharmacology.

The μ opioid receptor crystal structure with BU72 is a 1 covalent adduct 2

Thomas A. Munro, 2022 .

Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers.

Katharine K. Duncan, B. Cohen, W. Xu, 2008, Bioorganic & medicinal chemistry.

Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72

Thomas A. Munro, 2023, BMC Biology.

8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor

Katharine K. Duncan, B. Cohen, Wei Xu, 2007, Beilstein journal of organic chemistry.